Dr. Ho is leading four research teams at Columbia University to identify antivirals as well as monoclonal neutralizing antibodies that may be used to treat and prevent infection with SARS-CoV-2.
New York city is not only the U.S. epicenter of the SARS-CoV-2 pandemic, but it is also on the cutting edge research into understanding and identifying strategies to treat and prevent the infection.
Dr. David Ho, director of the ADARC, talks with Rachel Maddow about the consideration of existing drugs for the treatment of coronavirus infection and the prospects and timeline for an eventual cure.
Dr. David Ho is a world-renowned doctor and researcher on the frontlines of the current crisis. He joins Walter Isaacson to explain the lessons we should have learned from the 2003 SARS outbreak.
Dr. David Ho, director of ADARC, talks with Rachel Maddow about work being done to find a treatment for novel coronavirus infection. Researchers are hopeful to find an answer.
Remdesivir, a broad spectrum antiviral agent with activity against a broad range of RNA viruses including the SARS-CoV-2 virus, is considered a reasonable prospect of helping patients.
According to a release four research teams will share a $2.1 million grant to mount an aggressive effort to identify potential drugs and antibodies for use against the new coronavirus, 2019-nCoV.
Dr. David Ho discussed the challenges of treating the novel Coronavirus pneumonia (NCP) and the need to rapidly identify the exist antivirals for HIV infection to fight against the new Coronavirus.
